Mobile Navigation

Subscribe for the Newsletter

Company Info

Failed to load

Evonik

Evonik

CDMO / Excipients / Intermediates

Overview

Evonik Industries supports patient-friendly health care with a number of product developments for the pharmaceutical industry and medical technology. The company is contracted by pharmaceutical companies to produce active ingredient precursors, active ingredients and highly potent active ingredients under strict quality specifications. Evonik also produces pharmaceutical amino acids that are used in life-saving infusions and in the production of active pharmaceutical ingredients. Additionally, the company offers technology appropriate for the body, such as tablet coatings that release active ingredients at a precisely specified time to optimize efficacy. Evonik Industries is headquartered in Essen, Germany and owned by RAG Foundation.

Failed to load

Evonik
Contributions
10 Contributions1 / 1

Failed to load

The Value of a Custom Lipid Solutions Provider for mRNA Delivery
Custom Lipid Nanoparticle Development

The Value of a Custom Lipid Solutions Provider for mRNA Delivery

Lauren Longobardi, Ph.D.; Rima Jaber, Ph.D.; Sebastian Detlefsen, Dr.-Ing.

Evonik

PAO-11-022-CL-17Jan 05, 2023

Failed to load

New Polymer-Lipid Delivery System for mRNA
mRNA Delivery

New Polymer-Lipid Delivery System for mRNA

Andrea Engel, Ph.D.; Philipp Heller, Ph.D.

Evonik

PAO-05-022-CL-09May 31, 2022

Failed to load

Innovating at the Forefront of mRNA LNP Therapies
Parenteral Drug Delivery

Innovating at the Forefront of mRNA LNP Therapies

Evonik

PAO-02-22-R250-08Feb 10, 2022

Failed to load

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing
Lipid Nanoparticles

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Cole Byvelds, P.Eng.; Kristina Parrant

Evonik

PA656Dec 14, 2021

Failed to load

Focus on Commercial Parenteral Manufacturing at Evonik
Parenteral Manufacturing

Focus on Commercial Parenteral Manufacturing at Evonik

Caroline Hand; Maaike Everts, Ph.D.

Evonik

PAO-09-21-CL-15Oct 08, 2021

Failed to load

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing
Lipid Nanoparticles

Advancing Novel Therapeutics with End-to-End Lipid Nanoparticle Development and Manufacturing

Natalia Zisman

Evonik

PAO-07-21-CL-02Jul 12, 2021

Failed to load

Evonik
Drug Supply

Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin

Evonik

PR-M04-18-NI-94Apr 26, 2018

Failed to load

Evonik
Marketing

Evonik Launches a New MetAMINO® Marketing Campaign to the Middle East and African Markets At VIV MEA in Abu Dhabi

Evonik

PR-M02-18-NI-033Feb 09, 2018

Failed to load

Evonik
Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

Evonik

PR-M02-18-NI-024Feb 07, 2018

Failed to load

Evonik
Animal Nutrition

Evonik and Fufeng Group Enter Strategic Partnership for the Production of TherAMINO®

Evonik

PR-M01-18-NI-049Jan 18, 2018
1 / 1